FDA: Prasugrel [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-12-20 14:46 (4162 d 01:30 ago) – Posting: # 12085
Views: 28,300

Hi intuitivepharma,

❝ […] bioequivalence requirement [based on USFDA individual product bioequivalence recommendations] for Prasugrel Hydrochloride


❝ Can I justify my ANDA if test formulation is bioequivalent for the active metabolite (R-138727) and not bioequivalent for the Inactive metabolite R-95913?


Following the – nonbinding – recommendations of the guidance:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
77 visitors (0 registered, 77 guests [including 45 identified bots]).
Forum time: 17:16 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5